Navigation Links
China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
Date:5/26/2009

HARBIN, China, May 26 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today that they are preparing to significantly expand its shareholder and financial communication with the upcoming retention of an internationally-recognized investor relations firm. The Company has exhibited significant growth over the last year, despite the challenging broader economic environment, and understands the need to put in place an effective and professional investor relations program to communicate the Company's progress with current shareholders and the broader financial community.

    Our recent growth has been exhibited through the following statistics:

    -- First quarter revenues expanded to USD$3.3 million from USD$2.8
       million, representing quarter over quarter growth of approximately 18%;
    -- First quarter operating income grew to USD$880,530 from USD$721,695
       representing quarter over quarter growth of approximately 22%;
    -- Closed on an acquisition to significantly expand our future production
       capabilities from both the equipment and the raw material standpoint;
       and
    -- As of March 31, 2009 the Company maintained a strong balance sheet that
       consisted of USD$2.35 million of cash and no long term debt.

"We are very pleased with our operating performance and the future expansion plans that are in motion. We believe that with our current position in the market and the current stabilization in the Chinese economy that our shareholders will significantly benefit from increased investor communication and expanded market exposure." said Jinjiang Wang, President of China Kangtai Cactus. "We look forward to implementing a market awareness program and communicating our message with our current and future shareholder base."

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 18 product patents and is seeking another 12 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 12 provinces and 2 municipalities.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

    For more information, please contact:

     Chengzhi Wang
     General Manager
     China Kangtai Cactus Biotech, Inc.
     Tel:   +86-158-0451-2893
     Email: chinakangtai@gmail.com
     Web:  http://www.biocactus.com

'/>"/>
SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... Journal of Oral Implantology – Tooth loss is ... dental health, including complications with speech, eating, and overcompensation of mouth due to the ... teeth. As the number of tooth replacements increase, it is imperative to design an ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/26/2017)... Gainesville, FL (PRWEB) , ... April 26, 2017 ... ... health and human performance, is proud to announce that it has received 510(k) ... cutting-edge technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... 18, 2017 Viverae ® , a leader ... integration of IBM ® Watson Campaign Automation, implementing ... communications for a personalized experience. Through digital engagement, the ... health in real time. The enhanced experience drives engagement ... members, wherever they are in their journey to health. ...
Breaking Medicine Technology: